Abstract:Aim To investigate the correlation between clinicopathological features and risk stratification in cervical cancer patients, and evaluate the feasibility of tumor-infiltrating immune cells as prognostic biomarkers in clinical practice. Methods CD3+ tumor infiltrating T cells (TILs), CD45RO+ TILs, CD4+ TILs, CD8+ TILs, FOXP3+ TILs (regulatory T cells, Tregs), CD68+ tumor associated macrophages (TAMs), CD163+ TAMs, and PD-L1+ tumor cells were immunostained in formalin-fixed paraffin-embedded (PPFE) tissues from 96 cervical cancer patients. Immunostaining density and other clinicopathological features such as age, FIGO stage, histopathologic type, Ki67 index, HPV status, lymhovasular invasion status (LVI), lymph node metastasis, tumor size, stromal invasion status, surgical margin status, and parametrial invasion, were evaluated for their roles in risk stratification of cervical cancer patients. Results The results showed that significant differences of lymph node metastasis ( p = 0.003), surgical margin status ( p = 0.020), and stromal invasion status ( p = 0.004) existed between lVI(−) and LVI(+) patients. CD3+ TILs in the central tumor area ( p = 0.010), CD4+ TILs in the central tumor area ( p = 0.045), CD8 + TILs in the central tumor area ( p = 0.033), and CD8+ TILs in the invasive margin area ( p = 0.004) showed significant differences between lVI(−) and LVI(+) patients. When patients were grouped by status of lymph node metastasis, significant differences of FIGO stage ( p = 0.005), LVI status ( p = 0.003), CD3+ TILs in the central tumor area ( p = 0.045), CD45RO+ TILs in the central tumor area ( p = 0.033), and CD45RO+ TILs in the invasive margin area ( p = 0.028) were also observed. After the patients were stratified into low-, intermediate-, and high risk groups, significant differences of FIGO stage ( p = 0.018), status of lymph node metastasis ( p = 0.000), LVI status ( p = 0.000), parametrial invasion status (p=0.012), stromal invasion status ( p = 0.000), tumor growth pattern ( p = 0.015) and tumor size ( p = 0.000) were identified among 3 groups of patients, while only CD45RO+ TILs in the invasive margin area ( p = 0.018) and FOXP3+ TILs in the central tumor area ( p = 0.009) were statistically different among three groups of patients. Spearman’s correlation analysis demonstrated that FIGO stage, LVI status, status of lymph node metastasis, parametrial invasion, stromal invasion status, and tumor size positively correlated with risk stratification ( P = 0.005, 0.020, 0.000, 0.022, 0.000, and 0.000 respectively), while CD45RO+ TILs in the invasive margin area and FOXP3+ TILs in the central tumor area showed statistically negative correlation with risk stratification ( P = 0.031, 0.009 respectively). Conclusion Our study suggested that CD45RO+ TILs in the invasive margin area and FOXP3+ TILs in the central tumor area might be useful biomarkers for risk stratification in cervical cancer patients. Large cohort studies of cervical cancer patients are required to validate our hypothesis.

Tumor-to-stroma cd8+ t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

[Analysis of the Relationship Between Clinicopathological Features and Pelvic Lymph Node Metastasis in Patients with Early Stage Squamous Cell Carcinoma of the Uterine Cervix].

A Real-World Observational Study To Explore Clinical Characteristics Of Chinese Patients With T1 Non-Small Cell Lung Cancer Complicated With Lymph Metastases.

Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis

CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types

A novel parameter reflecting the interaction between CD8+ T cells and cancer-associated fibroblasts.

Plasma-based proteomic and metabolomic characterization of lung and lymph node metastases in cervical cancer patients

18F-FDG PET/CT semi-quantitative parameters combined with SCC-Ag in predicting lymph node metastasis in stage I-II cervical cancer

Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer

Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer

Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer

The Metastasis Status and Tumor Burden-Associated CA125 Level Combined with the CD4/CD8 Ratio Predicts the Prognosis of Patients with Advanced Pancreatic Cancer: A New Scoring System

WGCNA reveals a biomarker for cancer-associated fibroblasts to predict prognosis in cervical cancer

Combined Peripheral Natural Killer Cell and Circulating Tumor Cell Enumeration Enhance Prognostic Efficiency in Patients with Metastatic Triple-Negative Breast Cancer.

Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Lung Squamous Cell Carcinoma

Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer

Extracellular cancer‐associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor‐promoting roles and prognosis biomarker functions

The tumor–stroma ratio and the immune microenvironment improve the prognostic prediction of pancreatic ductal adenocarcinoma

Cancer-Associated Fibroblasts Correlate with Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer Patients